Matches in SemOpenAlex for { <https://semopenalex.org/work/W3204991753> ?p ?o ?g. }
Showing items 1 to 79 of
79
with 100 items per page.
- W3204991753 abstract "Background: The majority of patients with high-risk neuroblastoma (HR-NB) in low- and middle-income countries (LMIC) do not have access to autologous stem cell transplant (ASCT) and dinutuximab. Consolidation with non-myeloablative chemotherapy is not well-defined, and the outcomes are variable. We report a single-center outcome of patients with HR-NB, treated with non-myeloablative consolidation. A tabulated compilation of similar reports is included. Procedure: A retrospective chart review of patients with HR-NB was performed from January 2009 till June 2016. Patients were treated on the backbone of HR-NBL1/SIOPEN protocol. Treatment included induction with rapid-COJEC, surgery, consolidation, radiotherapy to the primary tumor, and differentiation therapy with isotretinoin. Consolidation included 4 cycles of topotecan, vincristine, and doxorubicin (TVD) instead of ASCT. Infusion of vincristine and doxorubicin were modified for ease and to enable administration in daycare. Results: Over 7-½ years, 28 patients with HR-NB were treated. Two (7%) patients had therapy-related mortality. A relapse or disease progression occurred in 11 (39%) patients at a median duration of 17 months (IQR: 5, 18). Treatment abandonment was observed in 4 (14%) patients. The 4-year event-free survival was 29.3%. The median follow up of disease-free patients is 49 months (IQR: 45, 79). Patients with relapse were not treated further. Conclusions: A 4-year EFS of 29.3% was observed when 4-cycles of TVD were administered instead of ASCT in patients with HR-NB. The study and the review will aid stakeholders in LMIC for decision-making while considering the options of treatment for HR-NB if access to ACST and dinutuximab is lacking." @default.
- W3204991753 created "2021-10-25" @default.
- W3204991753 creator A5000384489 @default.
- W3204991753 creator A5002148963 @default.
- W3204991753 creator A5006085055 @default.
- W3204991753 creator A5009698912 @default.
- W3204991753 creator A5021660840 @default.
- W3204991753 creator A5027917998 @default.
- W3204991753 creator A5038267722 @default.
- W3204991753 creator A5058590589 @default.
- W3204991753 creator A5069645910 @default.
- W3204991753 creator A5073573938 @default.
- W3204991753 creator A5076289830 @default.
- W3204991753 date "2020-07-20" @default.
- W3204991753 modified "2023-09-26" @default.
- W3204991753 title "Survival in patients with High-Risk Neuroblastoma without autologous stem cell transplant and dinutuximab" @default.
- W3204991753 doi "https://doi.org/10.22541/au.159526917.79951720" @default.
- W3204991753 hasPublicationYear "2020" @default.
- W3204991753 type Work @default.
- W3204991753 sameAs 3204991753 @default.
- W3204991753 citedByCount "0" @default.
- W3204991753 crossrefType "posted-content" @default.
- W3204991753 hasAuthorship W3204991753A5000384489 @default.
- W3204991753 hasAuthorship W3204991753A5002148963 @default.
- W3204991753 hasAuthorship W3204991753A5006085055 @default.
- W3204991753 hasAuthorship W3204991753A5009698912 @default.
- W3204991753 hasAuthorship W3204991753A5021660840 @default.
- W3204991753 hasAuthorship W3204991753A5027917998 @default.
- W3204991753 hasAuthorship W3204991753A5038267722 @default.
- W3204991753 hasAuthorship W3204991753A5058590589 @default.
- W3204991753 hasAuthorship W3204991753A5069645910 @default.
- W3204991753 hasAuthorship W3204991753A5073573938 @default.
- W3204991753 hasAuthorship W3204991753A5076289830 @default.
- W3204991753 hasBestOaLocation W32049917531 @default.
- W3204991753 hasConcept C126322002 @default.
- W3204991753 hasConcept C141071460 @default.
- W3204991753 hasConcept C143998085 @default.
- W3204991753 hasConcept C167135981 @default.
- W3204991753 hasConcept C2776694085 @default.
- W3204991753 hasConcept C2776715637 @default.
- W3204991753 hasConcept C2776755627 @default.
- W3204991753 hasConcept C2779050716 @default.
- W3204991753 hasConcept C2779429289 @default.
- W3204991753 hasConcept C2781209748 @default.
- W3204991753 hasConcept C54355233 @default.
- W3204991753 hasConcept C71924100 @default.
- W3204991753 hasConcept C81885089 @default.
- W3204991753 hasConcept C86803240 @default.
- W3204991753 hasConceptScore W3204991753C126322002 @default.
- W3204991753 hasConceptScore W3204991753C141071460 @default.
- W3204991753 hasConceptScore W3204991753C143998085 @default.
- W3204991753 hasConceptScore W3204991753C167135981 @default.
- W3204991753 hasConceptScore W3204991753C2776694085 @default.
- W3204991753 hasConceptScore W3204991753C2776715637 @default.
- W3204991753 hasConceptScore W3204991753C2776755627 @default.
- W3204991753 hasConceptScore W3204991753C2779050716 @default.
- W3204991753 hasConceptScore W3204991753C2779429289 @default.
- W3204991753 hasConceptScore W3204991753C2781209748 @default.
- W3204991753 hasConceptScore W3204991753C54355233 @default.
- W3204991753 hasConceptScore W3204991753C71924100 @default.
- W3204991753 hasConceptScore W3204991753C81885089 @default.
- W3204991753 hasConceptScore W3204991753C86803240 @default.
- W3204991753 hasLocation W32049917531 @default.
- W3204991753 hasOpenAccess W3204991753 @default.
- W3204991753 hasPrimaryLocation W32049917531 @default.
- W3204991753 hasRelatedWork W1545612850 @default.
- W3204991753 hasRelatedWork W1623990767 @default.
- W3204991753 hasRelatedWork W1966596410 @default.
- W3204991753 hasRelatedWork W1982388744 @default.
- W3204991753 hasRelatedWork W2006432950 @default.
- W3204991753 hasRelatedWork W2036726143 @default.
- W3204991753 hasRelatedWork W2370435708 @default.
- W3204991753 hasRelatedWork W2401224456 @default.
- W3204991753 hasRelatedWork W2920130377 @default.
- W3204991753 hasRelatedWork W4298309081 @default.
- W3204991753 isParatext "false" @default.
- W3204991753 isRetracted "false" @default.
- W3204991753 magId "3204991753" @default.
- W3204991753 workType "article" @default.